Book contents
- Surviving Prescribing
- Reviews
- Surviving Prescribing
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- Abbreviations
- Part 1 Introduction
- Part 2 Prescribing for Patient Groups
- Part 3 Emergency Prescribing
- Part 4 Gastrointestinal
- Part 5 Central Nervous System
- Part 6 Haematology
- Part 7 Surgery
- Part 8 Diabetes
- Part 9 Calculations
- Part 10 Interactions, Hypersensitivity and Contraindications
- Chapter 38 Drug Hypersensitivities and Contraindications
- Chapter 39 Interactions that Matter
- Part 11 Infections and Other Important Topics
- Index
Chapter 38 - Drug Hypersensitivities and Contraindications
from Part 10 - Interactions, Hypersensitivity and Contraindications
Published online by Cambridge University Press: 08 June 2020
- Surviving Prescribing
- Reviews
- Surviving Prescribing
- Copyright page
- Contents
- Contributors
- Preface to the Second Edition
- Abbreviations
- Part 1 Introduction
- Part 2 Prescribing for Patient Groups
- Part 3 Emergency Prescribing
- Part 4 Gastrointestinal
- Part 5 Central Nervous System
- Part 6 Haematology
- Part 7 Surgery
- Part 8 Diabetes
- Part 9 Calculations
- Part 10 Interactions, Hypersensitivity and Contraindications
- Chapter 38 Drug Hypersensitivities and Contraindications
- Chapter 39 Interactions that Matter
- Part 11 Infections and Other Important Topics
- Index
Summary
First do no harm’ is a fine principle; however, most medicines worth using have side effects, so it’s important that the prescriber can assess the risk/benefit ratio. This chapter provides examples of good advice (e.g. not to use NSAIDs in renal or liver impairment), overly cautious advice that may be flouted (e.g. cephalosporins in pencillin allergic patients) and advice that may appear overly cautious but should still be followed as there is a safer alternative (e.g.metformin in renal failure).
Keywords
- Type
- Chapter
- Information
- Surviving PrescribingA Practical Guide, pp. 171 - 174Publisher: Cambridge University PressPrint publication year: 2020